SANJIVANI PARANTERAL LTD. SHARE PRICE [LIVE]

BSE: INE860D01013   NSE: SANJIVIN   SECTOR: Pharma

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
N/A
Change:
BSE
54.25
Change:
NSE
BSE Click here to view BSE data
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in SANJIVANI PARANTERAL LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

SANJIVIN News

Frequently Asked Questions

What is the Share price of SANJIVANI PARANTERAL LTD. (SANJIVIN)?

SANJIVANI PARANTERAL LTD. (SANJIVIN) share price as of August 12, 2022, on BSE is Rs 54.25 (BSE).

Can I buy SANJIVANI PARANTERAL LTD. (SANJIVIN) shares?

Yes, You can buy SANJIVANI PARANTERAL LTD. (SANJIVIN) shares by opening a Demat account with Angel One.

How do I buy SANJIVANI PARANTERAL LTD. (SANJIVIN) from Angel One?

SANJIVANI PARANTERAL LTD. (SANJIVIN) share can be brought through the following modes:
  1. Direct investment: You can buy SANJIVANI PARANTERAL LTD. (SANJIVIN) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to SANJIVANI PARANTERAL LTD. (SANJIVIN) shares.

In which sector do SANJIVANI PARANTERAL LTD. (SANJIVIN) belong?

SANJIVANI PARANTERAL LTD. (SANJIVIN) belongs to Pharma.

About SANJIVIN

Today's live share price for SANJIVANI PARANTERAL LTD. is NSE: N/A, BSE: ₹ 54.25 with a current market capitalization of .

Incorporated as a public limited company in Oct.'94, Sanjivani Parenteral is jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative. The installed capacities for its products will be, 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules, taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.'96 to part-finance the project. The promoters have received firm enquiries from reputed phamaceutical companies like Merind, Lupin Laboratories and USV for the first year' production of liquid vials and ampoules. During the year 1998-99, the Company has been approved by the WHO GMP Certificate. The Company is hoping for export of its products in Africa, Europe & Latin America. The Company has also tied up with Cadila Ltd., Alkem Ltd., Indian Immunologicals Ltd for marketing its products. During the year 1999-2000, the company has tied-up with India's first ranked pharmaceutical giant Ranbaxy for manufacturing its products.

Read more